TransCode Therapeutics ( (RNAZ)) just unveiled an announcement. On December 19, 2025, TransCode Therapeutics appointed veteran life sciences executive Jack E. Stover to its board of directors, ...

TransCode Therapeutics, Inc. , a clinical stage company pioneering immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancer, today announced the publication of ...

It seems like everywhere you look you’re seeing 1111. On the clock, on license plates, home addresses, and being 11 minutes and 11 seconds away from your ...

Investing.com -- TransCode Therapeutics (NASDAQ:RNAZ) stock surged 18% on Tuesday after the company published preclinical data showing its lead candidate TTX-MC138 demonstrated therapeutic potential ...

This nine-digit number identifies your bank or credit union in a financial transaction. Many, or all, of the products featured on this page are from our advertising partners who compensate us when you ...

Glioblastoma is the most aggressive primary brain cancer, with median survival under two years from diagnosis despite current standard-of-care interventions. The molecular target of TTX-MC138, ...

Apple Creator Studio is taking on Adobe's dominant Creative Cloud by offering a selection of apps to create content, paid ...

Turn your Jellyfin or local library into ad-free TV channels you can flip through, complete with schedules, guides, and that ...

At ISE 2026, Kiloview will present its next-generation IP media management solution, designed to simplify, visualize, and optimize AV-over-IP workflows, making complex systems more reliable and ...

AI-generated playlists are undermining music discovery. Here's how owning your music helps escape filler, ads, and ...

But delivering broadcast-grade performance in a cloud environment is not simple. Video is uniquely demanding: latency must be ...